EMA: We're firmly convinced of the benefits of the Astrazeneca vaccine

The EMA is investigating reports of blood clots following the Astrazeneca vaccine, but does not change its recommendation.
Photo: PIROSCHKA VAN DE WOUW/REUTERS / X06750
Photo: PIROSCHKA VAN DE WOUW/REUTERS / X06750
BY RITZAU, TRANSLATED BY NIELSINE NIELSEN

The European Medicines Agency (EMA) remains "highly convinced" that the benefits of the Astrazeneca vaccine outweigh its risks, according to EMA Executive Director Emer Cooke at a Tuesday press conference.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading